NCT01632007View on ClinicalTrials.gov

Double-blind Comparative Study of SYR-472

PHASE3CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

May 1, 2012

Primary Completion Date

July 1, 2013

Study Completion Date

July 1, 2013

Conditions
Diabetes Mellitus
Interventions
DRUG

SYR-472

DRUG

Alogliptin 25 mg

DRUG

Placebo

Trial Locations (22)

Unknown

Akita

Matsudo-shi

Fukuoka

Fukuyama-shi

Ishikari-shi

Nakagawa-gun

Sapporo

Naka

Sagamihara-shi

Kumamoto

Kashiwara-shi

Osaka

Suita-shi

Arakawa-ku

Bunkyo-ku

Chiyoda-ku

Chuo-ku

Itabashi-ku

Katsushika-ku

Mitaka-shi

Shinjuku-ku

Shunan-shi

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY